Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Trulieve Cannabis Corp.TRUL · Entity 4418 | Director | April 09, 2021 | April 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Trulieve Cannabis Corp.
Report date April 09, 2021 · Filed April 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Multiple Voting SharesSEC Table II · derivative / convertible security | Direct | 3,266.6 |
Reported balance
After 2021-04-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-04-09 · Other · Acquired 3,266.6 · Balance 3,266.6 F1: Automatically converted from Super Voting Shares, without further action by the holder thereof, on March 21, 2021, as described in the Trulieve Cannabis Corp. Annual Report on Form 10-K filed on March 23, 2021. F2: Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date. F3: Pro rata distribution from Telogia Pharm, LLC, of which the reporting person is a non-managing member |
Filing footnotes · ownership attribution and instrument terms
F1: Automatically converted from Super Voting Shares, without further action by the holder thereof, on March 21, 2021, as described in the Trulieve Cannabis Corp. Annual Report on Form 10-K filed on March 23, 2021.
F2: Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date.
F3: Pro rata distribution from Telogia Pharm, LLC, of which the reporting person is a non-managing member
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2021 Filed Apr 14, 2021 00:26 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | OtherMultiple Voting Shares · Derivative | 3,266.6 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-015664 · doc4.xml · derivative · entry 1 Hackney George · CIK 0001840342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266.6 Underlying: Subordinate Voting Shares · 326,660 shares Expires not disclosed F1 · security: Automatically converted from Super Voting Shares, without further action by the holder thereof, on March 21, 2021, as described in the Trulieve Cannabis Corp. Annual Report on Form 10-K filed on March 23, 2021. F2 · derivative.exercise_price: Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date. F3 · kind: Pro rata distribution from Telogia Pharm, LLC, of which the reporting person is a non-managing member F2 · derivative.exercise_date: Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date. F2 · derivative.expiration_date: Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.